Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses

Journal of Immunology

Volumn 181, Issue 9, 2008, Pages 5912-5929

  Puliaeva, Irina ^a   Puliaev, Roman ^a   Shustov, Andrei ^b   Haas, Mark ^c   Via, Charles S ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; EPITOPE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CHRONIC DISEASE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; EFFECTOR CELL; GRAFT VERSUS HOST REACTION; HELPER CELL; HOST; IN VIVO STUDY; LUPUS LIKE SYNDROME; MALE; MOUSE; NONHUMAN; PARENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ACUTE DISEASE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; CROSS BREEDING; GENETICS; IMMUNOLOGY; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE ACTIVATION; METABOLISM; MORTALITY; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION; TUMOR CELL LINE;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD95; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELLS, CULTURED; CROSSES, GENETIC; DOWN-REGULATION; EPITOPES, T-LYMPHOCYTE; GRAFT VS HOST DISEASE; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 58749096040     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.9.5912     Document Type: Article

References (102)

1. Strasser, A., and M. Pellegrini. 2004. T-lymphocyte death during shutdown of an immune response. Trends Immunol. 25: 610-615. (Pubitemid 39369738)
2. Krammer, P. H., R. Arnold, and I. N. Lavrik. 2007. Life and death in peripheral T cells. Nat. Rev. Immunol. 7: 532-542.
3. Green, D. R., N. Droin, and M. Pinkoski. 2003. Activation-induced cell death in T cells. Immunol. Rev. 193: 70-81.
4. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407: 789-795.
5. Krueger, A., S. C. Fas, S. Baumann, and P. H. Krammer. 2003. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 193: 58-69. (Pubitemid 36688040)
6. Hildeman, D. A., Y. Zhu, T. C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16: 759-767.
7. Van Parijs, L., D. A. Peterson, and A. K. Abbas. 1998. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8: 265-274. (Pubitemid 28123753)
8. Van Parijs, L., A. Biuckians, and A. K. Abbas. 1998. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. J. Immunol. 160: 2065-2071.
9. Hildeman, D. A., Y. Zhu, T. C. Mitchell, J. Kappler, and P. Marrack. 2002. Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 14: 354-359. (Pubitemid 34327978)
10. Bouillet, P., D. Metcalf, D. C. Huang, D. M. Tarlinton, T. W. Kay, F. Kontgen, J. M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286: 1735-1738. (Pubitemid 129515880)
11. Hurov, J. B., T. S. Stappenbeck, C. M. Zmasek, L. S. White, S. H. Ranganath, J. H. Russell, A. C. Chan, K. M. Murphy, and H. Piwnica-Worms. 2001. Immune system dysfunction and autoimmune disease in mice lacking Emk (Par-1) protein kinase. Mol. Cell. Biol. 21: 3206-3219.
12. Spaner, D., K. Raju, B. Rabinovich, and R. G. Miller. 1999. A role for perforin in activation-induced T cell death in vivo: increased expansion of allogeneic perforin-deficient T cells in SCID mice. J. Immunol. 162: 1192-1199. (Pubitemid 29035453)
13. Hildeman, D. A., T. Mitchell, T. K. Teague, P. Henson, B. J. Day, J. Kappler, and P. C. Marrack. 1999. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10: 735-744. (Pubitemid 29302926)
14. Wong, B., and Y. Choi. 1997. Pathways leading to cell death in T cells. Curr. Opin. Immunol. 9: 358-364. (Pubitemid 27303505)
15. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17: 331-367. (Pubitemid 29241128)
16. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317.
17. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976. (Pubitemid 24106378)
18. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. Roberts, K. M. Debatin, A. Fischer, and J. P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349.
19. Fisher, G. H., F. J. Rosenberg, S. E. Straus, J. K. Dale, L. A. Middleton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946.
20. Rioux, J. D., and A. K. Abbas. 2005. Paths to understanding the genetic basis of autoimmune disease. Nature 435: 584-589. (Pubitemid 40825497)
21. Cohen, P. L., and R. A. Eisenberg. 1991. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269.
22. Warren, R. W., S. A. Caster, J. B. Roths, E. D. Murphy, and D. S. Pisetsky. 1984. The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains. Clin. Immunol. Immunopathol. 31: 65-77.
23. Mohan, C., S. Adams, V. Stanik, and S. K. Datta. 1993. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J. Exp. Med. 177: 1367-1381. (Pubitemid 23117127)
24. Hahn, B. H. 1998. Antibodies to DNA. N. Engl. J. Med. 338: 1359-1368.
25. + T cells. Nature 376: 181-184.
26. Wang, H., and M. J. Shlomchik. 1999. Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J. Exp. Med. 190: 639-649. (Pubitemid 29428648)
27. Jacobson, B. A., D. J. Panka, K. A. Nguyen, J. Erikson, A. K. Abbas, and A. Marshak-Rothstein. 1995. Anatomy of autoantibody production: dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity 3: 509-519.
28. Watanabe, D., T. Suda, and S. Nagata. 1995. Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells. Int. Immunol. 7: 1949-1956. (Pubitemid 3007594)
29. + T lymphocytes from MRL/lpr mice are resistant to receptor-mediated tolerance and apoptosis. J. Immunol. 151: 7233-7239.
30. Katagiri, T., P. L. Cohen, and R. A. Eisenberg. 1988. The lpr gene causes an intrinsic T cell abnormality that is required for hyperproliferation. J. Exp. Med. 167: 741-751. (Pubitemid 18111395)
31. Singer, G. G., A. C. Carrera, A. Marshak-Rothstein, C. Martinez, and A. K. Abbas. 1994. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr. Opin. Immunol. 6: 913-920.
32. Koshy, M., D. Berger, and M. K. Crow. 1996. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes. J. Clin. Invest. 98: 826-837. (Pubitemid 26349188)
33. Sobel, E. S., P. L. Cohen, and R. A. Eisenberg. 1993. lpr T cells are necessary for autoantibody production in lpr mice. J. Immunol. 150: 4160-4167.
34. Sobel, E. S., V. N. Kakkanaiah, M. Kakkanaiah, R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1994. T-B collaboration for autoantibody production in lpr mice is cognate and MHC-restricted. J. Immunol. 152: 6011-6016.
35. Peng, S. L., S. Fatenejad, and J. Craft. 1996. Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic αβ T cell: separation of autoantigen-specific and -nonspecific help. J. Immunol. 157: 5225-5230.
36. Koh, D. R., A. Ho, A. Rahemtulla, W. P. Fung-Leung, H. Griesser, and T. W. Mak. 1995. Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. Eur. J. Immunol. 25: 2558-2562.
37. Shlomchik, M. J., J. E. Craft, and M. J. Mamula. 2001. From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol 1: 147-153.
38. Lenardo, M., K. M. Chan, F. Hornung, H. McFarland, R. Siegel, J. Wang, and L. Zheng. 1999. Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu. Rev. Immunol. 17: 221-253. (Pubitemid 29241124)
39. Combadiere, B., C. Reis e Sousa, C. Trageser, L. X. Zheng, C. R. Kim, and M. J. Lenardo. 1998. Differential TCR signaling regulates apoptosis and immunopathology during antigen responses in vivo. Immunity 9: 305-313.
40. Hornung, F., L. Zheng, and M. J. Lenardo. 1997. Maintenance of clonotype specificity in CD95/Apo-1/Fas-mediated apoptosis of mature T lymphocytes. J. Immunol. 159: 3816-3822. (Pubitemid 127469637)
41. Hao, Z., B. Hampel, H. Yagita, and K. Rajewsky. 2004. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J. Exp. Med. 199: 1355-1365. (Pubitemid 38685727)
42. Stranges, P. B., J. Watson, C. J. Cooper, C. M. Choisy-Rossi, A. C. Stonebraker, R. A. Beighton, H. Hartig, J. P. Sundberg, S. Servick, G. Kaufmann, et al. 2007. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 26: 629-641.
43. Via, C. S., and G. M. Shearer. 1988. T-cell interactions in autoimmunity: insights from a murine model of graft-versus-host disease. Immunol. Today 9: 207-213. (Pubitemid 18166204)
44. Gleichmann, E., E. H. Van Elven, and J. P. Van der Veen. 1982. A systemic lupus erythematosus (SLE)-like disease in mice induced by abnormal T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur. J. Immunol. 12: 152-159.
45. Morris, S. C., R. L. Cheek, P. L. Cohen, and R. A. Eisenberg. 1990. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J. Exp. Med. 171: 503-517.
46. Eisenberg, R. 2003. The chronic graft-versus-host model of systemic autoimmunity. Curr. Dir. Autoimmun. 6: 228-244.
47. + CTL after reinfection. J. Immunol. 174: 3590-3597.
48. Thompson, B. S., and T. C. Mitchell. 2004. Measurement of daughter cell accumulation during lymphocyte proliferation in vivo. J. Immunol. Methods 295: 79-87.
49. + T cell activation and IFN-γ production. J. Immunol. 161: 2848-2855.
50. Shustov, A., I. Luzina, P. Nguyen, J. C. Papadimitriou, B. Handwerger, K. B. Elkon, and C. S. Via. 2000. Role of perforin in controlling B-cell hyperactivity and humoral autoimmunity. J. Clin. Invest. 106: R39-R47. (Pubitemid 30727599)
51. Puliaev, R., P. Nguyen, F. D. Finkelman, and C. S. Via. 2004. Differential requirement for IFN-γ in CTL maturation in acute murine graft-versus-host disease. J. Immunol. 173: 910-919. (Pubitemid 38924264)
52. Rus, V., V. Nguyen, R. Puliaev, I. Puliaeva, V. Zernetkina, I. Luzina, J. C. Papadimitriou, and C. S. Via. 2007. T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity. J. Immunol. 178: 3962-3972. (Pubitemid 46417667)
53. Passwell, J., G. F. Schreiner, M. Nonaka, H. U. Beuscher, and H. R. Colten. 1988. Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis. J. Clin. Invest. 82: 1676-1684. (Pubitemid 19007773)
54. Cooke, K. R., L. Kobzik, T. R. Martin, J. Brewer, J. Delmonte, Jr., J. M. Crawford, and J. L. Ferrara. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88: 3230-3239.
55. Via, C. S., S. O. Sharrow, and G. M. Shearer. 1987. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. J. Immunol. 139: 1840-1849.
56. Rozendaal, L., S. T. Pals, C. J. Melief, and E. Gleichmann. 1992. Protection from lethal graft-vs.-host disease by donor stem cell repopulation. Eur. J. Immunol. 22: 575-579.
57. Niculescu, F., T. Niculescu, P. Nguyen, R. Puliaev, J. C. Papadimitriou, A. Gaspari, H. Rus, and C. S. Via. 2005. Both apoptosis and complement membrane attack complex deposition are major features of murine acute graft-vs.-host disease. Exp. Mol. Pathol. 79: 136-145. (Pubitemid 41262495)
58. 1 model of graft-vs.-host disease as a model of in vivo T cell function and immunomodulation. Curr. Med. Chem. Immunol. Endocr. Metab. Agents 5: 575-583.
59. + T cells. J. Immunol. 155: 2396-2406.
60. + T cells. J. Immunol. 146: 4138-4148.
61. Rolink, A. G., and E. Gleichmann. 1983. Allosuppressor- and allohelper-T cells in acute and chronic graft-vs.-host (GVH) disease: III. Different Lyt subsets of donor T cells induce different pathological syndromes. J. Exp. Med. 158: 546-558.
62. 1 recipients carrying mutations at H-2K and/or I-A. J. Exp. Med. 157: 755-771.
63. Chang, C. H., S. C. Hong, C. C. Hughes, C. A. Janeway, Jr., and R. A. Flavell. 1995. CIITA activates the expression of MHC class II genes in mouse T cells. Int. Immunol. 7: 1515-1518.
64. Kosmatopoulos, K., D. S. Algara, and S. Orbach-Arbouys. 1987. Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction. J. Immunol. 138: 1038-1041. (Pubitemid 17017881)
65. Puliaev, R., I. Puliaeva, L. A. Welniak, A. E. Ryan, M. Haas, W. J. Murphy, and C. S. Via. 2008. CTL-promoting effects of CD40 stimulation outweigh B cell-stimulatory effects resulting in B cell elimination and disease improvement in a murine model of lupus. J. Immunol. 181: 47-61.
66. Kagi, D., B. Odermatt, and T. W. Mak. 1999. Homeostatic regulation of CD8+ T cells by perforin. Eur. J. Immunol. 29: 3262-3272. (Pubitemid 29484217)
67. De Saint Basile, G., and A. Fischer. 2001. The role of cytotoxicity in lymphocyte homeostasis. Curr. Opin. Immunol. 13: 549-554.
68. + T cells during acute graft-versus-host disease. Blood 105: 2023-2027.
69. Butte, M. J., M. E. Keir, T. B. Phamduy, A. H. Sharpe, and G. J. Freeman. 2007. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 27: 111-122.
70. Sobel, E. S., T. Katagiri, K. Katagiri, S. C. Morris, P. L. Cohen, and R. A. Eisenberg. 1991. An intrinsic B cell defect is required for the production of autoantibodies in the lpr model of murine systemic autoimmunity. J. Exp. Med. 173: 1441-1449.
71. Maksimow, M., T. S. Soderstrom, S. Jalkanen, J. E. Eriksson, and A. Hanninen. 2006. Fas costimulation of naive CD4 T cells is controlled by NF-κB signaling and caspase activity. J. Leukocyte Biol. 79: 369-377. (Pubitemid 44831169)
72. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178: 2231-2235.
73. Kennedy, N. J., T. Kataoka, J. Tschopp, and R. C. Budd. 1999. Caspase activation is required for T cell proliferation. J. Exp. Med. 190: 1891-1896.
74. Van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4: 321-328. (Pubitemid 126349699)
75. Refaeli, Y., L. Van Parijs, S. I. Alexander, and A. K. Abbas. 2002. Interferon γ is required for activation-induced death of T lymphocytes. J. Exp. Med. 196: 999-1005.
76. Gleichmann, E., and H. Gleichmann. 1985. Pathogenesis of graft-versus-host reactions (GVHR) and GVH-like diseases. J. Invest. Dermatol. 85: 115s-120s. (Pubitemid 16235464)
77. Via, C. S., A. Shustov, V. Rus, T. Lang, P. Nguyen, and F. D. Finkelman. 2001. In vivo neutralization of TNF-α promotes humoral autoimmunity by preventing the induction of CTL. J. Immunol. 167: 6821-6826.
78. Via, C. S., and F. D. Finkelman. 1993. Critical role of interleukin-2 in the development of acute graft-versus-host disease. Int. Immunol. 5: 565-572. (Pubitemid 23209409)
79. Via, C. S., V. Rus, M. K. Gately, and F. D. Finkelman. 1994. IL-12 stimulates the development of acute graft-versus-host disease in mice that normally would develop chronic, autoimmune graft-versus-host disease. J. Immunol. 153: 4040-4047.
80. Via, C. S., P. Nguyen, A. Shustov, J. Drappa, and K. B. Elkon. 1996. A major role for the Fas pathway in acute graft-versus-host disease. J. Immunol. 157: 5387-5393.
81. + T cells. Proc. Natl. Acad. Sci. USA 97: 1707-1712.
82. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187: 123-128. (Pubitemid 28044827)
83. + T cells. J. Immunol. 165: 5537-5543.
84. Fields, M. L., S. A. Nish, B. D. Hondowicz, M. H. Metzgar, G. N. Wharton, A. J. Caton, and J. Erikson. 2005. The influence of effector T cells and Fas ligand on lupus-associated B cells. J. Immunol. 175: 104-111. (Pubitemid 40884306)
85. Drake, W. P., V. M. Byrd, and N. J. Olsen. 2003. Reactivation of systemic lupus erythematosus after initiation of highly active antiretroviral therapy for acquired immunodeficiency syndrome. J. Clin. Rheumatol. 9: 176-180.
86. 1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161: 378-391.
87. Wofsy, D. 1986. Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. J. Immunol. 136: 4554-4560. (Pubitemid 16090676)
88. + T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus. J. Exp. Med. 193: 329-337.
89. + T cells from lupus-prone Fas-intact MRL mice display TCR-mediated hyperproliferation due to intrinsic threshold defects in activation. J. Immunol. 174: 5100-5109.
90. + T cells in vivo. J. Immunol. 163: 3138-3142.
91. ras. J. Immunol. 160: 1497-1503.
92. Lawson, B. R., G. J. Prud'homme, Y. Chang, H. A. Gardner, J. Kuan, D. H. Kono, and A. N. Theofilopoulos. 2000. Treatment of murine lupus with cDNA encoding IFN-γR/Fc. J. Clin. Invest. 106: 207-215.
93. Balomenos, D., R. Rumold, and A. N. Theofilopoulos. 1998. Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101: 364-371.
94. Kagi, D., B. Ledermann, K. Burki, R. M. Zinkernagel, and H. Hengartner. 1996. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu. Rev. Immunol. 14: 207-232. (Pubitemid 26130183)
95. Walsh, C. M., M. Matloubian, C. C. Liu, R. Ueda, C. G. Kurahara, J. L. Christensen, M. T. Huang, J. D. Young, R. Ahmed, and W. R. Clark. 1994. Immune function in mice lacking the perforin gene. Proc. Natl. Acad. Sci. USA 91: 10854-10858.
96. Peng, S. L., J. Moslehi, M. E. Robert, and J. Craft. 1998. Perforin protects against autoimmunity in lupus-prone mice. J. Immunol. 160: 652-660.
97. Berke, G. 1995. The CTL's kiss of death. Cell 81: 9-12.
98. + lymphocytes delete activated macrophages through the Fas/APO-1 antigen pathway. Proc. Natl. Acad. Sci. USA 92: 11225-11229.
99. Tsokos, G. C. 2004. Overview of cellular immune function in systemic lupus erythematosus. In Systemic Lupus Erythematosus. R. G. Lahita, ed. Elsevier, Amsterdam, pp. 29-92.
100. + T helper cell function in association with autoimmunity. J. Exp. Med. 168: 2165-2181.
101. Via, C. S., G. C. Tsokos, B. Bermas, M. Clerici, and G. M. Shearer. 1993. T cell-antigen-presenting cell interactions in human systemic lupus erythematosus: evidence for heterogeneous expression of multiple defects. J. Immunol. 151: 3914-3922.
102. H-derived major histocompatibility complex class I-binding epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus. J. Exp. Med. 196: 731-741.